Institutional investors hold a majority ownership of INCY through the 103.40% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2015, these large investors purchased a net $17.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WELLINGTON MANAGEMENT CO. LLP Bought 12.0 Million shares of Incyte Corp
BAKER BROS. ADVISORS LP Bought 4.0 Million shares of Incyte Corp
SV LIFE SCIENCES MANAGERS LLP Bought 111.1 Thousand shares of Incyte Corp